|
1
|
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
|
J Clin Oncol
|
2002
|
3.30
|
|
2
|
Results of multimodal treatment for desmoplastic small round cell tumors.
|
J Pediatr Surg
|
2005
|
2.68
|
|
3
|
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
|
J Clin Oncol
|
2006
|
1.97
|
|
4
|
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.80
|
|
5
|
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.77
|
|
6
|
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.58
|
|
7
|
Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2010
|
1.55
|
|
8
|
Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.46
|
|
9
|
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.42
|
|
10
|
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.39
|
|
11
|
Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study.
|
J Natl Cancer Inst
|
2010
|
1.38
|
|
12
|
Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumor.
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.35
|
|
13
|
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.33
|
|
14
|
Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.29
|
|
15
|
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
|
Cancer
|
2006
|
1.28
|
|
16
|
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.27
|
|
17
|
Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.25
|
|
18
|
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
|
J Neurooncol
|
2009
|
1.23
|
|
19
|
Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
|
J Clin Oncol
|
2013
|
1.18
|
|
20
|
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study.
|
Radiother Oncol
|
2006
|
1.17
|
|
21
|
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.17
|
|
22
|
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.16
|
|
23
|
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.15
|
|
24
|
Prediction of in vivo radiation dose status in radiotherapy patients using ex vivo and in vivo gene expression signatures.
|
Radiat Res
|
2011
|
1.14
|
|
25
|
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
|
J Clin Oncol
|
2007
|
1.14
|
|
26
|
Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
|
J Clin Oncol
|
2007
|
1.13
|
|
27
|
Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience.
|
J Pediatr Hematol Oncol
|
2003
|
1.12
|
|
28
|
Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.11
|
|
29
|
Intensity-modulated radiotherapy.
|
Cancer J
|
2002
|
1.07
|
|
30
|
PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools.
|
J Pediatr Hematol Oncol
|
2007
|
1.04
|
|
31
|
Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group.
|
J Clin Oncol
|
2009
|
1.02
|
|
32
|
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.01
|
|
33
|
Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation.
|
Radiat Res
|
2014
|
0.98
|
|
34
|
Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.
|
Int J Cancer
|
2013
|
0.96
|
|
35
|
Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.96
|
|
36
|
Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.96
|
|
37
|
The challenging role of radiation therapy for very young children with rhabdomyosarcoma.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.95
|
|
38
|
Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
|
Pediatr Blood Cancer
|
2010
|
0.94
|
|
39
|
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.93
|
|
40
|
Radiotherapy after surgical resection for head and neck mucosal melanoma.
|
Am J Clin Oncol
|
2010
|
0.92
|
|
41
|
Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.92
|
|
42
|
Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma.
|
Pediatr Blood Cancer
|
2014
|
0.91
|
|
43
|
Nasopharyngeal carcinoma: recognizing the radiographic features in children.
|
AJNR Am J Neuroradiol
|
2005
|
0.91
|
|
44
|
Reirradiation for recurrent medulloblastoma.
|
Cancer
|
2011
|
0.91
|
|
45
|
Parameningeal rhabdomyosarcoma: outcomes and opportunities.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.90
|
|
46
|
Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy.
|
Cancer
|
2012
|
0.90
|
|
47
|
Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland.
|
Cancer
|
2009
|
0.89
|
|
48
|
Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
|
Head Neck
|
2008
|
0.88
|
|
49
|
Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
|
Int J Cancer
|
2014
|
0.88
|
|
50
|
The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.88
|
|
51
|
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.87
|
|
52
|
Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases.
|
Pediatr Blood Cancer
|
2013
|
0.87
|
|
53
|
Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma.
|
Pediatr Blood Cancer
|
2014
|
0.86
|
|
54
|
Clear cell sarcoma of the gastrointestinal tract after very low-dose therapeutic radiation therapy: a case report.
|
J Pediatr Surg
|
2012
|
0.86
|
|
55
|
Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
|
Pediatr Blood Cancer
|
2012
|
0.86
|
|
56
|
Radiation-induced salivary gland tumors: a report of 18 cases and a review of the literature.
|
Cancer J
|
2004
|
0.84
|
|
57
|
The management of treatment-related esophageal complications in children and adolescents with cancer.
|
J Pediatr Surg
|
2006
|
0.83
|
|
58
|
Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.83
|
|
59
|
Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma.
|
Radiat Oncol
|
2013
|
0.82
|
|
60
|
Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: an institutional review.
|
J Pediatr Surg
|
2013
|
0.82
|
|
61
|
Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: a report on toxicity and efficacy from a prospective pilot phase II study.
|
Pediatr Blood Cancer
|
2012
|
0.81
|
|
62
|
Local control, survival, and operative morbidity and mortality after re-resection, and intraoperative radiation therapy for recurrent or persistent primary high-risk neuroblastoma.
|
J Pediatr Surg
|
2011
|
0.81
|
|
63
|
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.80
|
|
64
|
Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.80
|
|
65
|
Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
|
Am J Clin Oncol
|
2015
|
0.78
|
|
66
|
Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2012
|
0.78
|
|
67
|
Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.77
|
|
68
|
Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors.
|
Pediatr Blood Cancer
|
2008
|
0.77
|
|
69
|
Factors associated with relapse and survival in Wilms tumor: a multivariate analysis.
|
J Pediatr Surg
|
2012
|
0.77
|
|
70
|
Exenteration and Custom Implant Brachytherapy as a Treatment for Recurrent Primary Extraskeletal Orbital Ewing Sarcoma.
|
Ophthal Plast Reconstr Surg
|
2015
|
0.75
|
|
71
|
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.
|
J Neurooncol
|
2015
|
0.75
|
|
72
|
Phantosmia during radiation therapy: a report of 2 cases.
|
J Child Neurol
|
2012
|
0.75
|
|
73
|
Contrast media use in radiation oncology: a prospective, controlled educational intervention study with retrospective analysis of patient outcomes.
|
J Am Coll Radiol
|
2010
|
0.75
|
|
74
|
Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma.
|
J Pediatr Hematol Oncol
|
2017
|
0.75
|
|
75
|
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.75
|
|
76
|
Symptomatic Chiari type I malformation after radiation therapy in an infant: case report.
|
Neurosurgery
|
2007
|
0.75
|
|
77
|
Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experience.
|
Brachytherapy
|
2003
|
0.75
|
|
78
|
Whole-lung irradiation in the treatment of metastatic synovial sarcoma.
|
Pediatr Blood Cancer
|
2014
|
0.75
|
|
79
|
Ureteral reconstruction for retroperitoneal tumors in children.
|
J Pediatr Surg
|
2007
|
0.75
|
|
80
|
Intraoperative phosphorus-32 brachytherapy plaque for multiply recurrent high-risk epidural neuroblastoma.
|
J Neurosurg Pediatr
|
2014
|
0.75
|